Skip to main content
. 2020 May 7;16:393–401. doi: 10.2147/TCRM.S249208

Figure 2.

Figure 2

Kaplan-Meier survival curves of incidence of CV events in GnRH agonists and antagonist-treated patients at 5 years considering (A) overall cohort, (B) sub-cohort of patients without previous CV events.

Abbreviations: CV, cardiovascular; GnRH-a, gonadotropin-releasing hormone agonists; GnRH-ant, gonadotropin-releasing hormone antagonist.